Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ofloxacin
- Therapeutic area
- Anti-infectives
- Drug class
- Fluoroquinolone antibacterials
- ATC
- J01MA
- Strength
- 200 mg/100 mL
- Dosage form
- IV infusion
- Pack
- 100 ml
- Registration no.
- 053254
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Mediate Pharmaceutical Pvt Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What S-vid inf (Ofloxacin) is used for
Ofloxacin is an antibiotic from the quinolone (fluoroquinolone) group, the same family as ciprofloxacin and levofloxacin. It kills the bacteria that cause an infection. It comes as tablets for infections inside the body and as eye drops for eye infections. Because the tablets can cause rare but serious and sometimes long-lasting side effects, UK guidance says they should only be used when the usual antibiotics are not suitable.
- Urine infections, including bladder and kidney infections
- Chest infections, such as pneumonia and flare-ups of bronchitis or COPD
- Some genital and sexually transmitted infections in men and women, such as infections of the urethra or cervix, and gonorrhoea when tests show the germ is sensitive
- Specialist use in UK hospitals for some infections of the testicles or prostate (epididymitis or prostatitis) and pelvic inflammatory disease, on the advice of an infection or sexual health specialist
- Eye infections such as bacterial conjunctivitis and corneal ulcers (as eye drops)
Get medical help straight away if
- Call an ambulance or go to the emergency department for sudden, severe pain in the stomach, chest or back. This can be a sign of a tear or bulge in the main blood vessel (aorta).
- Get emergency help for signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, trouble breathing or swallowing, or hives.
- Get emergency help for fits (seizures), or for any thoughts of harming yourself or ending your life. Mental health changes can happen even after the first tablet.
- Stop taking it and contact a doctor straight away for pain or swelling in a tendon, often near the ankle. Rest the area. This can happen even months after stopping.
Side effects, warnings and interactions for Ofloxacin
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Ofloxacin
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Ofloxacin is right for you and the dose.
- Brucellosis: an alternative partner for rifampicin in adults
- Conjunctivitis (pink eye): For bacterial pink eye when your doctor thinks treatment is needed. Chloramphenicol drops are a common first choice in UK guidance. Fluoroquinolone drops are kept for more severe infection and for contact lens wearers. Ointment is sometimes used at night. They do not help viral or allergic pink eye
- Typhoid fever: formerly standard
About S-vid inf 200 mg/100 mL IV infusion
S-vid inf 200 mg/100 mL IV infusion contains Ofloxacin 200 mg/100 mL. It is registered with DRAP by Mediate Pharmaceutical Pvt Ltd (registration no. 053254). Its official price is PKR 190.65 for a pack of 100 ml. This price has applied since 1 July 2025. 4 other brands of Ofloxacin 200 mg/100 mL (IV infusion) are registered in Pakistan. Compare all brands and prices →
All 4 other brands of Ofloxacin 200 mg/100 mL infusion in Pakistan
These 4 brands are alternatives (substitutes) to S-vid inf: each contains Ofloxacin 200 mg/100 mL infusion. Ask your doctor or pharmacist before you switch brands.
Sorted by price per unit, lowest first. The lowest is Ofbel (GT Pharma Pvt. Ltd) at PKR 194 per unit; the highest is OKSIN at PKR 310. All prices are official DRAP prices.
How old is this price? It was fixed on 1 July 2025 and has not changed since — that is 16 months ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for S-vid inf, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Mediate Pharmaceutical Pvt Ltd, Karachi
- DRAP registration
- 053254
- Phone
- +92 21 35074746-7
- info@mediatepharma.com
- Website
- https://www.mediatepharma.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 18 October 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (100 ml). Current price PKR 190.65, effective 1 Jul 2025.
Cite this price history
MedInfoBase. S-vid inf 200 mg/100 mL, 100 ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/s-vid-inf-200-mg-100-ml-053254-100-ml-mediate-pharmaceutical-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 190.65 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 053254Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.